Key result
Non-ruptured TCFA, not non-culprit plaque rupture, identifies plaques at higher risk for MACE.
Why the study?
Non-culprit plaque rupture has been associated with worse short-term outcomes, but its role in predicting long-term clinical outcomes remains undefined.
Does the presence of OCT-identified non-culprit plaque rupture predict long-term major adverse cardiac events in patients with acute myocardial infarction?
Cohort (n=1,312)
Does the presence of OCT-identified non-culprit plaque rupture predict long-term major adverse cardiac events in patients with acute myocardial infarction?
In patients with acute myocardial infarction, the poor long-term prognosis associated with non-culprit plaque rupture is predominantly driven by the presence of non-ruptured thin-cap fibroatheroma (TCFA) rather than the plaque rupture itself.
Non-culprit TCFA detection may refine post-AMI risk stratification; supports consensus on vulnerability but leaves open need for targeted trials.
Background Subclinical plaque rupture (i.e. non-culprit plaque rupture) was thought to be a sign of pancoronary vulnerability. Patients with non-culprit plaque rupture tended to have worse short-term outcome. The role of non-culprit plaque rupture on long-term clinical outcome remains undefined. Purpose This study aimed to observe the role of non-culprit plaque rupture in predicting the long-term recurrent adverse cardiac events in acute myocardial infarction (AMI) population. Methods From January 2017 and December 2021, patients presenting with AMI who underwent 3-vessel optical coherence tomography (OCT) before interventional therapy were studied. Patients and lesions were classified according to the presence or absence of OCT-identified plaque rupture at the non-culprit sites. In the sub-analysis, patients and lesions were further divided based on plaque rupture and/or non-ruptured thin-cap fibroatheroma (TCFA) at the non-culprit segments. Non-ruptured TCFA was defined as a lesion with TCFA but not a plaque rupture. All enrolled patients were followed for up to five years. Major adverse cardiac events (MACE) consisted of cardiac death, non-fatal myocardial infarction, and unplanned ischemia-driven revascularization. Results A total of 1312 AMI patients with 5273 non-culprit lesions were included in this study. Non-culprit plaque rupture was detected in 226 patients and 282 lesions. During a median 4.1year follow-up, non-culprit lesion-related MACEs occurred more frequently in patients with versus without plaque rupture, primarily attributable to increased risk of non-fatal MI and unplanned revascularization. However, non-culprit lesion-related MACEs was similar for lesions with versus without plaque rupture. In multivariable models, non-culprit plaque rupture was associated with non-culprit lesion-related MACEs at the patient level, but not at the lesion level. In the sub-analysis, non-ruptured TCFA was identified in 319 patients and 428 lesions. Non-ruptured TCFA was associated with non-culprit lesion-related MACEs but not plaque rupture, both at the patient and lesion levels in multivariable models. Conclusions Non-ruptured TCFA, not plaque rupture can identify plaques at increased risk of subsequent events. Patients with non-culprit plaque rupture had a poor long-term prognosis, which is predominantly due to the effect of non-ruptured TCFA.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2025) conducted a cohort in acute myocardial infarction (AMI) (n=1,312). Non-culprit plaque rupture vs. Absence of non-culprit plaque rupture was evaluated on Major adverse cardiac events (MACE) consisting of cardiac death, non-fatal myocardial infarction, and unplanned ischemia-driven revascularization. In 1,312 AMI patients followed for 4.1 years, non-ruptured thin-cap fibroatheroma, rather than non-culprit plaque rupture, was independently associated with subsequent non-culprit lesion-related MACE.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: